Saul Goodman reports on Eli Lilly's new daily obesity pill, orforglipron, which shows promise in weight loss and diabetes management, potentially shaking up the market with a needle-free alternative.
Saul Goodman reports on Eli Lilly's new daily obesity pill, orforglipron, which shows promise in weight loss and diabetes management, potentially shaking up the market with a needle-free alternative.

Better Call Lilly! Because Needles? Not Cool!

Alright folks Saul Goodman here your friendly neighborhood lawyer and now apparently health guru! I'm hearin' whispers from the big pharma boys down at Eli Lilly. Apparently they've cooked up somethin' special – a daily pill called orforglipron. Seems like they're sayin' it helps folks with the beetus (that's Type 2 diabetes for you fancy types) AND shed a few pounds. I'm talkin' a potential win win baby! No more needles! 'Cause let's be honest who likes those things? Not even Gus Fring and that guy was… meticulous.

Breaking Bad News for Novo Nordisk? Maybe…

Now Eli Lilly is playin' their cards close to the vest but the early buzz is that this pill could give Novo Nordisk (the Ozempic people) a serious run for their money. A pill people! Easier to swallow than the truth sometimes am I right? And cheaper to manufacture? Ding ding ding! We have a winner! But hold your horses folks. Just because it looks good on paper doesn't mean it's a guaranteed slam dunk. Remember Tuco Salamanca? Looked tough but… well you know.

The Good the Bad and the Nauseous

So the pill helps people lose weight (around 8% – not bad!) and it lowers blood sugar. But here's the catch: some folks got a little… queasy. Nausea vomiting the whole shebang. But hey no pain no gain right? Kinda like buildin' a meth empire in the desert. Okay maybe not THAT extreme. But you get the idea. And that's better than a poke in the eye with a sharp stick if you ask me. The side effects ain't exactly smooth like my courtroom maneuvers but they're manageable apparently.

Analysts are Buzzing but are They High on Their Own Supply?

Wall Street analysts are all over this thing predictin' a multi billion dollar market. $150 BILLION by the early 2030s?! That's enough to make even Walter White blush! But remember these are the same guys who told you Blockbuster was a solid investment. Still they're sayin' Eli Lilly is way ahead of the competition. Like three years ahead. That's an eternity in the fast paced world of pharma and cookin'... er I mean legal business. “Yeah science!”

From Desert to Pill: Manufacturing Miracles

Lilly's CEO David Ricks is toutin' the fact that this pill can be made in bulk and shipped around the world. Accessibility for all baby! Which means more folks can get their hands on this potential miracle drug. It could alleviate the shortage of the current injectables which is great! It's a small thing but it's good to know that the world can find relief from something. If I can change and you can change everybody can change!

Saul's Verdict: Proceed with Caution... but Invest!

Alright here's the bottom line folks. Eli Lilly's orforglipron pill sounds promising. Like REALLY promising. But let's not get ahead of ourselves. There are still a few hurdles to jump and the FDA is not always the most lenient of juries. Tread lightly. However if you're lookin' to make a smart investment… Well let's just say 'I know a guy… who knows a guy…' Just sayin'. Remember 'If you're committed enough you can make any story work. I once convinced a woman I was Kevin Costner and it worked because I believed it'!


Comments

  • No comments yet. Become a member to post your comments.